Labiana Health

Labiana Health Operating Expenses

The Total Operating Expenses of Labiana Health (LAB.MC) as of Nov 19, 2026 is 22.69 M EUR. In the previous year, Total Operating Expenses was 18.24 M EUR — a change of 24.44% (higher).

Operating Expenses

22.69 MEUR

YoY

24.44%

Last updated:

Total Operating Expenses of Labiana Health is 2022 22.69 M EUR. Total Operating Expenses of Labiana Health was 2021 18.24 M EUR. It decreases by 24.44% higher compared to the previous year.

The Labiana Health Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
25.73 M EUR
Jan 1, 2019
27.95 M EUR
Jan 1, 2020
17.94 M EUR
Jan 1, 2021
18.24 M EUR
Jan 1, 2022
22.69 M EUR
The Labiana Health Operating Expenses history
YEAROperating ExpensesYoY
22.69 MEUR+24.44%
18.24 MEUR+1.64%
17.94 MEUR-35.80%
27.95 MEUR+8.63%
25.73 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labiana Health Stock analysis

What does Labiana Health do? Labiana Health SA generates revenue through the development, manufacturing, and marketing of animal and human medicines. The company focuses on drug research and development, including galenic and analytical development, as well as drug manufacturing, which encompasses formulation development and bacterial vaccine manufacturing. Regulatory services for pharmaceutical product registration in global markets also contribute to its income. Its subsidiaries operate in Ecuador, Mexico, Serbia, and Turkey, serving markets for both animal and human pharmaceutical products. The company's primary products include sterile and lyophilized dosage forms, which are manufactured for use in animal and human medicine. These products are sold to customers in the pharmaceutical industry, including distributors and healthcare providers in the regions where Labiana Health SA has a presence. The company’s R&D and manufacturing capabilities support the production of medicines that meet regulatory standards for global markets. Labiana Health SA’s business model relies on its subsidiaries in Ecuador, Mexico, Serbia, and Turkey to facilitate market access and distribution. The company’s revenue streams are derived from the sale of pharmaceutical products, regulatory services, and the development of new drug formulations. Its focus on sterile and lyophilized dosage forms positions it within the specialized pharmaceutical manufacturing sector, targeting both animal and human medicine segments. Labiana Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labiana Health stock

Total Operating Expenses of Labiana Health is 22.69 M EUR in 2022.

Total Operating Expenses of Labiana Health changed from 18.24 M EUR to 22.69 M EUR, representing a 24.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Labiana Health since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Labiana Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Labiana Health

All Key Metrics — Labiana Health